The Oxford Science Park has appointed DTRE and Cushman & Wakefield as joint agents to advise on and manage the leasing of its office and laboratory space.
The instruction comprises more than 600,000 sq ft of existing space as well as future developments totalling over 650,000 sq ft.
The move comes shortly after Swiss pharma manufacturing firm Lonza withdrew its plans to establish a hub in Oxford. The firm was eyeing a take-up of the top floor of the newly completed Iversen Building (pictured), which provides 88,000 sq ft of lab-ready space and is the latest addition to the park.
Rory Maw, chief executive at the Oxford Science Park, said: “With the Iversen Building now completed, we have already started work on three major lab-ready buildings totalling 450,000 sq ft for delivery in 2026. This will take total space on the park to more than 1m sq ft and provide space for the next generation of life sciences and technology companies.”
There are also 15 other buildings within the park, which are available to bespoke specifications, with adaptable layouts to facilitate the full spectrum of lab and office requirements.
Existing occupiers on the park include Blue Earth Diagnostics, Oxford Nanopore Technologies, Oxgene, ProImmune, Oxford Science Enterprises, Enara Bio, Sitryx, Ochre Bio, Scancell, Evox Therapeutics, Exscientia and Intuitive Surgical.
The park is also the new Oxford home for the Ellison Institute of Technology. Late last year, the institute’s revised plans for the transformation of Littlemore House were approved by the local council.
Matt Smith, head of science and technology at DTRE, said: “The enormous demand for specialist space in the UK is showing no signs of waning, and the Oxford Science Park has been essential to filling the supply void.
“Its proximity to the Oxford biotech and technology communities is hard to beat but, perhaps more importantly, the array of facilities within the park means it is able to cater for occupiers from conception to commercialisation, making it a home for both early-stage spin-outs and multinationals.”
Image © Oxford Science Park
Send feedback to Evelina Grecenko
Follow Estates Gazette
